290 related articles for article (PubMed ID: 6285725)
1. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy.
Sibrack CD; McLaren C; Barry DW
Am J Med; 1982 Jul; 73(1A):372-5. PubMed ID: 6285725
[TBL] [Abstract][Full Text] [Related]
2. Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child.
Sibrack CD; Gutman LT; Wilfert CM; McLaren C; St Clair MH; Keller PM; Barry DW
J Infect Dis; 1982 Nov; 146(5):673-82. PubMed ID: 6290575
[TBL] [Abstract][Full Text] [Related]
3. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
[TBL] [Abstract][Full Text] [Related]
4. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
McLaren C; Chen MS; Ghazzouli I; Saral R; Burns WH
Antimicrob Agents Chemother; 1985 Dec; 28(6):740-4. PubMed ID: 3002245
[TBL] [Abstract][Full Text] [Related]
5. An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice.
Sakuma S; Yamamoto M; Kumano Y; Mori R
Arch Virol; 1988; 101(3-4):169-82. PubMed ID: 2845890
[TBL] [Abstract][Full Text] [Related]
6. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus.
Shimada Y; Suzuki M; Shirasaki F; Saito E; Sogo K; Hasegawa M; Takehara K; Phromjai J; Chuhjo T; Shiraki K
J Med Virol; 2007 Nov; 79(11):1731-40. PubMed ID: 17854045
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of sensitivity of acyclovir of herpes simplex virus clinical isolates.
McLaren C; Sibrack CD; Barry DW
Am J Med; 1982 Jul; 73(1A):376-9. PubMed ID: 6285726
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS.
Gateley A; Gander RM; Johnson PC; Kit S; Otsuka H; Kohl S
J Infect Dis; 1990 Apr; 161(4):711-5. PubMed ID: 2156946
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Snoeck R; Andrei G; GĂ©rard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
[TBL] [Abstract][Full Text] [Related]
10. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM
Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635
[TBL] [Abstract][Full Text] [Related]
11. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
Field HJ; Lay E
Antiviral Res; 1984 Apr; 4(1-2):43-52. PubMed ID: 6331304
[TBL] [Abstract][Full Text] [Related]
12. Experimental skin infection with an acyclovir resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection.
Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
Arch Virol; 1980; 65(3-4):237-46. PubMed ID: 6251784
[TBL] [Abstract][Full Text] [Related]
13. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir.
Field HJ; Neden J
Antiviral Res; 1982 Oct; 2(5):243-54. PubMed ID: 6295272
[TBL] [Abstract][Full Text] [Related]
14. Successful foscarnet therapy for mucocutaneous infection with herpes simplex virus in a recipient after unrelated bone marrow transplantation.
Iino T; Gondo H; Ohno Y; Minagawa H; Iwasaki H; Maruyama T; Nakashima H; Niho Y
Bone Marrow Transplant; 1996 Dec; 18(6):1185-8. PubMed ID: 8971394
[TBL] [Abstract][Full Text] [Related]
15. Acyclovir therapy for the orofacial and ganglionic HSV infection in hairless mice.
Park NH; Pavan-Langston D; Hettinger ME
J Dent Res; 1980 Dec; 59(12):2080-6. PubMed ID: 6941998
[No Abstract] [Full Text] [Related]
16. Effect of acyclovir on genital infection with herpes simplex virus types 1 and 2 in the guinea pig.
Landry ML; Lucia HL; Hsiung GD; Pronovost AD; Dann PR; August MJ; Mayo DR
Am J Med; 1982 Jul; 73(1A):143-50. PubMed ID: 6285705
[TBL] [Abstract][Full Text] [Related]
17. Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
Klein RJ
Am J Med; 1982 Jul; 73(1A):138-42. PubMed ID: 6285703
[TBL] [Abstract][Full Text] [Related]
18. In vitro sensitivity to acyclovir in genital herpes simplex viruses from acyclovir-treated patients.
McLaren C; Corey L; Dekket C; Barry DW
J Infect Dis; 1983 Nov; 148(5):868-75. PubMed ID: 6313820
[TBL] [Abstract][Full Text] [Related]
19. Topical therapeutic efficacy of 9-(2-hydroxyethoxymethyl)guanine and 5-iodo-5'-amino-2',5'-dideoxyuridine on oral infection with herpes simplex virus in mice.
Park NH; Pavan-Langston D; Hettinger ME; McLean SL; Albert DM; Lin TS; Prusoff WH
J Infect Dis; 1980 May; 141(5):575-9. PubMed ID: 6966305
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir.
Collins P; Ellis MN
J Med Virol; 1993; Suppl 1():58-66. PubMed ID: 8245894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]